Preclinical Validation of [(177)Lu]Lu-AKIR001, a CD44v6-Targeted Radiotherapeutic Entering First-in-Human Trials
CD44v6靶向放射性药物[(177)Lu]Lu-AKIR001的临床前验证,即将进入首次人体试验
期刊:
影响因子:
doi:10.2967/jnumed.125.270782
Mortensen, Anja C L; Mohajershojai, Tabassom; Gustafsson, Amanda; Berglund, Hanna; Selvaraju, Ram Kumar; Hofström, Camilla; Persson, Helena; Ohlin, Mats; Tran, Thuy A; Morén, Anton Forsberg; Ochniewicz, Piotr; Zedenius, Jan; Bernhardt, Peter; Frejd, Fredrik Y; Nestor, Marika